{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T18:29:05Z","timestamp":1792348145632,"version":"4.4.0"},"reference-count":75,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2689614","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:44:18Z","timestamp":1782924258000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit\u2013cost analysis"],"prefix":"10.1080","volume":"25","author":[{"given":"Ellie","family":"Tunnicliffe","sequence":"first","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Napier","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claud","family":"Theakston","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Chin","family":"Yen","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Subramaniyan","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Brassel","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherina","family":"Zakikhany-Gilg","sequence":"additional","affiliation":[{"name":"Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Palmborg","sequence":"additional","affiliation":[{"name":"Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mate","family":"Szilcz","sequence":"additional","affiliation":[{"name":"Viti Science AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Toghanian","sequence":"additional","affiliation":[{"name":"Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Hedberg","sequence":"additional","affiliation":[{"name":"Karolinska Institute","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Svensson","sequence":"additional","affiliation":[{"name":"University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyan","family":"Hu","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Steuten","sequence":"additional","affiliation":[{"name":"Office of Health Economics","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"FOHM. Covid-19 \u2013 disease statistics [Internet]. 2025 [cited 2025 Sep 23]. Available from: https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistik-a-o\/sjukdomsstatistik\/covid-19\/"},{"key":"e_1_3_3_3_1","unstructured":"FOHM. Influenza in Sweden \u2013 season 2024\u20132025 [Internet]. 2025 [cited 2025 Sep 23]. Available from: https:\/\/www.folkhalsomyndigheten.se\/publikationer-och-material\/publikationsarkiv\/i\/influenza-in-sweden-season-2024-2025\/"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2025.2543077"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00176-2"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04249-x"},{"key":"e_1_3_3_7_1","unstructured":"United Nations Department of Economic and Social Affairs Population Division. World population prospects 2024 [Internet]. 2024 [cited 2025 Oct 23]. Available from: https:\/\/population.un.org\/wpp\/downloads?folder=Standard%20Projections&group=Most%20used"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100343"},{"key":"e_1_3_3_9_1","unstructured":"Socialstyelsen. Statistikdatabaser - D\u00f6dsorsaksstatistik - Resultat [Internet]. 2025 [cited 2025 Aug 21]. Available from: https:\/\/sdb.socialstyrelsen.se\/if_dor\/resultat.aspx"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12956"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03431-7"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040753"},{"key":"e_1_3_3_13_1","unstructured":"WHO Regional Office for Europe. European Immunization Agenda 2030: Technical Progress Report 2023 [Internet]. 2024 [cited 2025 Sep 23]. Available from: https:\/\/www.who.int\/europe\/publications\/i\/item\/WHO-EURO-2024-10246-50018-75270"},{"key":"e_1_3_3_14_1","unstructured":"Statistics Sweden. The future population of Sweden 2025\u20132070 [Internet]. 2025 [cited 2025 Sep 23]. (BE51 - Demographic reports). Available from: https:\/\/www.scb.se\/hitta-statistik\/statistik-efter-amne\/befolkning-och-levnadsforhallanden\/befolkningens-sammansattning-och-utveckling\/befolkningsframskrivningar\/produktrelaterat\/rapporter\/sveriges-framtida-befolkning-2025-2070\/"},{"key":"e_1_3_3_15_1","unstructured":"FOHM. Responsibility for national programmes [Internet]. 2022 [cited 2025 Aug 26]. Available from: https:\/\/www.folkhalsomyndigheten.se\/the-public-health-agency-of-sweden\/communicable-disease-control\/vaccinations\/responsibility-for-national-programmes\/"},{"key":"e_1_3_3_16_1","unstructured":"FOHM. Recommended vaccinations [Internet]. 2025 [cited 2025 Jul 31]. Available from: https:\/\/www.folkhalsomyndigheten.se\/the-public-health-agency-of-sweden\/communicable-disease-control\/vaccinations\/recommended-vaccinations\/"},{"key":"e_1_3_3_17_1","unstructured":"FOHM. Vaccination programmes [Internet]. 2025 [cited 2025 Nov 20]. Available from: https:\/\/www.folkhalsomyndigheten.se\/the-public-health-agency-of-sweden\/communicable-disease-control\/vaccinations\/vaccination-programmes\/"},{"key":"e_1_3_3_18_1","unstructured":"FOHM. Vaccination against influenza [Internet]. 2025 [cited 2025 Aug 28]. Available from: https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/vaccinationer-i-sverige\/influensa\/"},{"key":"e_1_3_3_19_1","unstructured":"FOHM. New recommendations on vaccination against COVID-19 from 1 September 2025 [Internet]. 2025 [cited 2025 Aug 28]. Available from: https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/rekommendationer-for-vaccination\/rekommendationer-om-vaccination-mot-covid-19\/nya-rekommendationer-om-vaccination-mot-covid-19-fran-1-september-2025\/"},{"key":"e_1_3_3_20_1","unstructured":"FOHM. Questions and answers about vaccination against RSV [Internet]. 2023 [cited 2025 Aug 28]. Available from: https:\/\/www.folkhalsomyndigheten.se\/smittskydd-beredskap\/vaccinationer\/fragor-och-svar\/faq-om-rs-virus-och-vaccination\/"},{"key":"e_1_3_3_21_1","unstructured":"Mattsson T. Lex-Atlas: covid-19 [Internet]. 2021 [cited 2025 Aug 26]. Update on Sweden\u2019s vaccination course: four-phased plan and regional differences. Available from: https:\/\/lexatlas-c19.org\/update-on-swedens-vaccination-course-four-phased-plan-and-regional-differences\/"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2536093"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2536092"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4015886"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1780847"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab118"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/jmahp12040026"},{"key":"e_1_3_3_28_1","unstructured":"OECD. OECD [Internet]. 2025 [cited 2025 Aug 29]. Average annual wages. Available from: https:\/\/www.oecd.org\/en\/data\/indicators\/average-annual-wages.html"},{"key":"e_1_3_3_29_1","unstructured":"Statista. Statista [Internet]. 2025 [cited 2025 Oct 23]. Sweden: unemployment rate by age group 2023. Available from: https:\/\/www.statista.com\/statistics\/527330\/sweden-unemployment-rate-by-age-group\/"},{"key":"e_1_3_3_30_1","unstructured":"Region Stockholm. Pneumococci - vaccinationst\u00e4ckning.pdf | The Caregiver\u2019s Guide [Internet]. 2024 [cited 2025 Oct 17]. Available from: https:\/\/vardgivarguiden.se\/kunskapsstod\/smittskydd\/amnesomraden\/vaccination\/pneumokocker-vaccinering-av-riskgrupper\/"},{"key":"e_1_3_3_31_1","unstructured":"CDC. Pneumococcal Disease [Internet]. 2025 [cited 2025 Oct 17]. Pneumococcal Vaccine Recommendations. Available from: https:\/\/www.cdc.gov\/pneumococcal\/hcp\/vaccine-recommendations\/index.html"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408544"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2026.101520"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2436183"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf061"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213836"},{"key":"e_1_3_3_37_1","unstructured":"CDC. Flu vaccines work [Internet]. 2025 [cited 2025 Oct 17]. Past Seasons\u2019 Vaccine Effectiveness Estimates. Available from: https:\/\/www.cdc.gov\/flu-vaccines-work\/php\/effectiveness-studies\/past-seasons-estimates.html"},{"key":"e_1_3_3_38_1","unstructured":"FOHM. Vaccination against covid-19 in health economic evaluation [Internet]. 2025 [cited 2025 Sep 24]. Available from: https:\/\/www.folkhalsomyndigheten.se\/publikationer-och-material\/publikationsarkiv\/v\/vaccination-mot-covid-19-en-halsoekonomisk-utvardering\/"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2383343"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.05.02.25326904"},{"key":"e_1_3_3_41_1","unstructured":"FOHM. FOHM data on file. 2025."},{"key":"e_1_3_3_42_1","unstructured":"TLV. Amendment to the dental and pharmaceutical benefits Board\u2019s general advice (TLVAR 2003: 2) on economic evaluations [Internet]. 2017 [cited 2025 Oct 17]. Available from: https:\/\/www.tlv.se\/download\/18.467926b615d084471ac3230c\/1510316374332\/TLVAR_2017_1.pdf"},{"key":"e_1_3_3_43_1","unstructured":"Broberg T Wettergren H. Analysis method and socio-economic calculation values for the transport sector ASEK 8.0. Internet. 2024 [cited 2025 Jul 31]. Available from: https:\/\/bransch.trafikverket.se\/contentassets\/0e5777a6301e4134a6e8365fc20c0e0e\/asek-8.0-2-april-2024.pdf"},{"key":"e_1_3_3_44_1","unstructured":"International Monetary Fund. World economic outlook (October 2025) - implied PPP conversion rate [Internet]. 2025 [cited 2025 Dec 18]. Available from: https:\/\/www.imf.org\/external\/datamapper\/PPPEX@WEO"},{"key":"e_1_3_3_45_1","unstructured":"World Bank. World Bank Open Data [Internet]. GDP deflator: linked series. Available from 2025 [cited 2025 Nov 11]. Available from: https:\/\/data.worldbank.org"},{"key":"e_1_3_3_46_1","unstructured":"WHO. Immunization Agenda 2030 [Internet]. 2020 [cited 2025 Aug 28]. Available from: https:\/\/www.immunizationagenda2030.org\/"},{"key":"e_1_3_3_47_1","unstructured":"Vaccines Europe. 15 years on: updating the EU\u2019s 75% uptake target to manage the triple threat of flu COVID-19 and RSV\u2019 16 October 2024 Brussels (belgium) and online [Internet]. 2024 [cited 2025 Aug 21]. Available from: https:\/\/www.vaccineseurope.eu\/media-hub\/events\/15-years-on-updating-the-eus-75-uptake-target-to-manage-the-triple-threat-of-flu-covid-19-and-rsv-16-october-2024-brussels-belgium-and-online\/"},{"key":"e_1_3_3_48_1","unstructured":"EHMA. EHMA call to action: establishing a European vaccination coverage target for pneumococcal disease in adults. EHMA [Internet]. 2025 [cited 2025 Nov 20]. Available from: https:\/\/ehma.org\/ehma-call-to-action-establishing-a-european-vaccination-coverage-target-for-pneumococcal-disease-in-adults\/"},{"key":"e_1_3_3_49_1","unstructured":"ECDC. Vaccine Scheduler | ECDC [Internet]. 2026 [cited 2026 Mar 18]. Available from: https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=53&SelectedCountryIdByDisease=-1"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2279394"},{"key":"e_1_3_3_51_1","unstructured":"du Travail M. Sant\u00e9 de la Familles des S et des Travail M du Sant\u00e9 de la Familles des S et des. Minist\u00e8re du Travail de la Sant\u00e9 des Solidarit\u00e9s et des Familles [Internet]. [cited 2025 Sep 3]. Available from: https:\/\/sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal"},{"key":"e_1_3_3_52_1","unstructured":"Ministero della Salute. Campagna di vaccinazione anti Covid-19. Internet. 2025 [cited 2025 Oct 16]. Available from: https:\/\/www.salute.gov.it\/new\/it\/tema\/covid-19\/campagna-di-vaccinazione-anti-covid-19\/"},{"key":"e_1_3_3_53_1","unstructured":"UKHSA. Who\u2019s eligible for the 2025 COVID-19 vaccine or \u2018Autumn booster\u2019? \u2013 UK health security agency [Internet]. 2025 [cited 2025 Sep 3]. Available from: https:\/\/ukhsa.blog.gov.uk\/2025\/06\/26\/whos-eligible-for-the-2025-covid-19-vaccine-or-autumn-booster\/"},{"key":"e_1_3_3_54_1","unstructured":"THL. THL [Internet]. 2025 [cited 2025 Sep 3]. Available from: https:\/\/thl.fi\/aiheet\/infektiotaudit-ja-rokotukset\/rokotteet-a-o\/koronarokotteet"},{"key":"e_1_3_3_55_1","unstructured":"FHI. Folkehelseinstituttet [Internet]. 2025 [cited 2025 Sep 3]. Available from: https:\/\/www.fhi.no\/va\/voksenvaksinasjon\/vaksiner-mot-sykdommene-a-a\/vaksiner-i-voksenvaksinasjonsprogrammet\/koronavaksine\/"},{"key":"e_1_3_3_56_1","unstructured":"Jamet M El-Atillah I. Euronews [Internet]. 2023 [cited 2025 Sep 3]. Greying but staying: The Europeans still working in their 70s. Available from: https:\/\/www.euronews.com\/next\/2023\/02\/22\/the-rise-of-elderly-workers-who-works-beyond-the-age-of-65-or-75-in-europe"},{"key":"e_1_3_3_57_1","unstructured":"LegalClarity. What is the retirement age in Sweden? Legal Clarity [Internet]. 2025 [cited 2025 Sep 3]. Available from: https:\/\/legalclarity.org\/what-is-the-retirement-age-in-sweden\/"},{"key":"e_1_3_3_58_1","unstructured":"OECD. OECD data explorer \u2022 health expenditure and financing [Internet]. 2025 [cited 2025 Aug 26]. https:\/\/data-explorer.oecd.org\/vis?fs[0]=Topic%2C1%7CHealth%23HEA%23%7CHealth%20expenditure%20and%20financing%23HEAEXP%23&fs[1]=Reference%20area%2C0%7CSweden%23SWE%23&fs[2]=Health%20function%2C1%7CTotal%23T%23%7CPreventive%20care%23HC6%23&pg=0&fc=Health%20function&snb=1&df[ds]=dsDisseminateFinalDMZ&df[id]=DSD_SHA%40DF_SHA&df[ag]=OECD.ELS.HD&df[vs]=1.0&dq=SWE.A.EXPHEALTH.PTB1GQ.T.T%2BHC62%2BHC6.T.T\u2026&to[TIME_PERIOD]=false&vw=tb&pd=2020%2C2024&isAvailabilityDisabled=false."},{"key":"e_1_3_3_59_1","unstructured":"OECD. OECD [Internet]. 2025 [cited 2025 Aug 26]. Nominal gross domestic product (GDP). Available from: https:\/\/www.oecd.org\/en\/data\/indicators\/nominal-gross-domestic-product-gdp.html"},{"key":"e_1_3_3_60_1","unstructured":"World Bank. World Bank Open Data [Internet]. World Bank Open Data. Available from 2025 [cited 2025 Aug 29]. Available from: https:\/\/data.worldbank.org"},{"key":"e_1_3_3_61_1","unstructured":"FEAM. Immunisation for old adults in europe: scientific and social strategies [Internet]. 2022 [cited 2025 Oct 17]. Available from: https:\/\/www.feam.eu\/wp-content\/uploads\/Report-Immunisation-for-old-adults-in-Europe.pdf"},{"key":"e_1_3_3_62_1","unstructured":"Vaccines Europe. Adult immunisation. Vaccines Europe [Internet]. 2023 [cited 2025 Oct 17]. Available from: https:\/\/www.vaccineseurope.eu\/life-course-immunisation\/adult-immunisation\/"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.17.30523"},{"key":"e_1_3_3_64_1","unstructured":"FOHM. Information to the vaccinated individual about the national vaccination register [Internet]. 2023 [cited 2026 Mar 5]. Available from: https:\/\/www.folkhalsomyndigheten.se\/the-public-health-agency-of-sweden\/communicable-disease-control\/vaccinations\/vaccination-register-and-vaccination-coverage\/information-to-the-vaccinated-individual\/"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2025.2580785"},{"key":"e_1_3_3_66_1","unstructured":"FOHM. People from the age of 75 are recommended vaccination against RS virus [Internet]. 2023 [cited 2025 Aug 28]. Available from: https:\/\/www.folkhalsomyndigheten.se\/nyheter-och-press\/nyhetsarkiv\/2023\/september\/personer-fran-75-ar-rekommenderas-vaccination-mot-rs-virus\/"},{"key":"e_1_3_3_67_1","unstructured":"Swedish Medical Products Agency. New action plan for better use of medicines [Internet]. 2025 [cited 2025 Nov 18]. Available from: https:\/\/www.lakemedelsverket.se\/sv\/nyheter\/ny-handlingsplan-for-battre-lakemedelsanvandning"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1017\/bca.2022.9"},{"key":"e_1_3_3_69_1","unstructured":"Directorate-General for Traffic. UPDATE OF THE MONETARY VALUE OF a STATISTICAL LIFE IN Spain [Internet]. 2025. Available from: https:\/\/www.dgt.es\/export\/sites\/web-DGT\/.galleries\/downloads\/conoce_la_dgt\/que-hacemos\/conocimiento-e-investigacion\/Update_of_the_monetary_value_of_a_statistical_life_in_Spain_20250131.pdf"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.04.001"},{"key":"e_1_3_3_71_1","unstructured":"US Department of Transportation. Departmental guidance on valuation of a statistical life in economic analysis [Internet]. 2025 [cited 2025 Aug 12]. Available from: https:\/\/www.transportation.gov\/office-policy\/transportation-policy\/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2012.09.007"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1787\/9789264130807-en"},{"key":"e_1_3_3_74_1","unstructured":"Washington State Institute for Public Policy. Benefit-Cost Results [Internet]. 2024 [cited 2025 Oct 23]. Available from: https:\/\/www.wsipp.wa.gov\/BenefitCost?topicId=10"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2021.100096"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67635"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2689614","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2026.2689614","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2689614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:33:58Z","timestamp":1783485238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2689614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2689614"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2689614","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2689614"}}